Ceterix Orthopaedics’ NovoStitch Technology Sees Positive Results in Efficacy Studies

Ceterix Orthopaedics announced findings from recent biomechanical studies of its proprietary NovoStitch technology.

Advertisement

Gulf Breeze, Fla.-based Andrews Institute physician, Adam Anz, MD, presented results of a study that evaluated different types of suture patterns for repairing meniscus root tears in the knee at the Arthroscopy Association of North America annual meeting. The study found that sutures placed using the NovoStitch device come closer to restoring the native root strength than previous techniques.

 

Results from another study, presented at the Orthopaedic Research Society conference, demonstrated that suture patterns delivered with the NovoStitch meet or exceed the strength of those delivered via the gold-standard open surgical approach for two common types of tears.

 

Ceterix Orthopaedics is a developer of novel surgical tools for minimally invasive soft tissue procedures.

More Articles on Devices:

Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.